Found: 6
Select item for more details and to access through your institution.
Difference in Treatment Effect Between Intravitreal Aflibercept Injection and Laser by Baseline Factors in Diabetic Macular Edema.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Evaluation of Very High- and Very Low-Dose Intravitreal Aflibercept in Patients with Neovascular Age-Related Macular Degeneration.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2012, v. 28, n. 6, p. 581, doi. 10.1089/jop.2011.0261
- By:
- Publication type:
- Article
Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical Trial.
- Published in:
- JAMA Ophthalmology, 2023, v. 141, n. 9, p. 834, doi. 10.1001/jamaophthalmol.2023.2421
- By:
- Publication type:
- Article
Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Intravitreal Aflibercept Injection in Eyes With Substantial Vision Loss After Laser Photocoagulation for Diabetic Macular Edema: Subanalysis of the VISTA and VIVID Randomized Clinical Trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Initiation of neural induction by FGF signalling before gastrulation.
- Published in:
- Nature, 2000, v. 406, n. 6791, p. 74, doi. 10.1038/35017617
- By:
- Publication type:
- Article